MASTECTOMIE RADICALE ET RADICALE MODIFIEE DANS LE TRAITEMENT DU CANCER DU SEIN

Translated title of the contribution: Radical mastectomy and modified radical mastectomy in the treatment of breast cancer

J. Lacour, M. Le, J. Y. Petit

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

We studied first the long term results in a series of 1,139 immediately operable breast cancers, treated by a protocol which gave an important role to extended radical mastectomy (radical mastectomy with internal mammary node dissection). No difference in survival was noted according to the surgical procedure used, and the extended mastectomy does not seem to have demonstrated its superiority. Its value could be judged in a more rigorous manner thanks to the results of an international therapeutic trial, comparing radical mastectomy with extended radical mastectomy. Results were improved by the extended procedure in only one sub-group of patients, whose tumors were located in central or inner quadrants, T 1 or T 2, with positive axillary nodes: these patients represent 13% of patients with immediately operable tumors. Taking these results into account a new protocol has been adopted at the Institut Gustave-Roussy: T 1 cancers will be the object of a therapeutic trial between conservative treatment and modified radical mastectomy; T 2 (internal or central) cancers, with axillary nodal involvement will be treated by extended radical mastectomy; and, T 2 tumors (external) and all T 3 tumors will be treated by a modified radical mastectomy.

Original languageFrench
Pages (from-to)593-602
Number of pages10
JournalBulletin du Cancer
Volume64
Issue number4
Publication statusPublished - 1977

Fingerprint

Radical Mastectomy
Modified Radical Mastectomy
Extended Radical Mastectomy
Breast Neoplasms
Neoplasms
Therapeutics
Mastectomy
Dissection
Breast
Survival

ASJC Scopus subject areas

  • Oncology

Cite this

MASTECTOMIE RADICALE ET RADICALE MODIFIEE DANS LE TRAITEMENT DU CANCER DU SEIN. / Lacour, J.; Le, M.; Petit, J. Y.

In: Bulletin du Cancer, Vol. 64, No. 4, 1977, p. 593-602.

Research output: Contribution to journalArticle

@article{08c006b74b0845ffba267c40948ddc76,
title = "MASTECTOMIE RADICALE ET RADICALE MODIFIEE DANS LE TRAITEMENT DU CANCER DU SEIN",
abstract = "We studied first the long term results in a series of 1,139 immediately operable breast cancers, treated by a protocol which gave an important role to extended radical mastectomy (radical mastectomy with internal mammary node dissection). No difference in survival was noted according to the surgical procedure used, and the extended mastectomy does not seem to have demonstrated its superiority. Its value could be judged in a more rigorous manner thanks to the results of an international therapeutic trial, comparing radical mastectomy with extended radical mastectomy. Results were improved by the extended procedure in only one sub-group of patients, whose tumors were located in central or inner quadrants, T 1 or T 2, with positive axillary nodes: these patients represent 13{\%} of patients with immediately operable tumors. Taking these results into account a new protocol has been adopted at the Institut Gustave-Roussy: T 1 cancers will be the object of a therapeutic trial between conservative treatment and modified radical mastectomy; T 2 (internal or central) cancers, with axillary nodal involvement will be treated by extended radical mastectomy; and, T 2 tumors (external) and all T 3 tumors will be treated by a modified radical mastectomy.",
author = "J. Lacour and M. Le and Petit, {J. Y.}",
year = "1977",
language = "Francese",
volume = "64",
pages = "593--602",
journal = "Bulletin du Cancer",
issn = "0007-4551",
publisher = "John Libbey Eurotext",
number = "4",

}

TY - JOUR

T1 - MASTECTOMIE RADICALE ET RADICALE MODIFIEE DANS LE TRAITEMENT DU CANCER DU SEIN

AU - Lacour, J.

AU - Le, M.

AU - Petit, J. Y.

PY - 1977

Y1 - 1977

N2 - We studied first the long term results in a series of 1,139 immediately operable breast cancers, treated by a protocol which gave an important role to extended radical mastectomy (radical mastectomy with internal mammary node dissection). No difference in survival was noted according to the surgical procedure used, and the extended mastectomy does not seem to have demonstrated its superiority. Its value could be judged in a more rigorous manner thanks to the results of an international therapeutic trial, comparing radical mastectomy with extended radical mastectomy. Results were improved by the extended procedure in only one sub-group of patients, whose tumors were located in central or inner quadrants, T 1 or T 2, with positive axillary nodes: these patients represent 13% of patients with immediately operable tumors. Taking these results into account a new protocol has been adopted at the Institut Gustave-Roussy: T 1 cancers will be the object of a therapeutic trial between conservative treatment and modified radical mastectomy; T 2 (internal or central) cancers, with axillary nodal involvement will be treated by extended radical mastectomy; and, T 2 tumors (external) and all T 3 tumors will be treated by a modified radical mastectomy.

AB - We studied first the long term results in a series of 1,139 immediately operable breast cancers, treated by a protocol which gave an important role to extended radical mastectomy (radical mastectomy with internal mammary node dissection). No difference in survival was noted according to the surgical procedure used, and the extended mastectomy does not seem to have demonstrated its superiority. Its value could be judged in a more rigorous manner thanks to the results of an international therapeutic trial, comparing radical mastectomy with extended radical mastectomy. Results were improved by the extended procedure in only one sub-group of patients, whose tumors were located in central or inner quadrants, T 1 or T 2, with positive axillary nodes: these patients represent 13% of patients with immediately operable tumors. Taking these results into account a new protocol has been adopted at the Institut Gustave-Roussy: T 1 cancers will be the object of a therapeutic trial between conservative treatment and modified radical mastectomy; T 2 (internal or central) cancers, with axillary nodal involvement will be treated by extended radical mastectomy; and, T 2 tumors (external) and all T 3 tumors will be treated by a modified radical mastectomy.

UR - http://www.scopus.com/inward/record.url?scp=0017698921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017698921&partnerID=8YFLogxK

M3 - Articolo

VL - 64

SP - 593

EP - 602

JO - Bulletin du Cancer

JF - Bulletin du Cancer

SN - 0007-4551

IS - 4

ER -